Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Thursday, November 21, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Thursday, November 21, 2024 | Latest Paper
Subscribe Now

TRENDING:

Sharon Batt

A national pharmacare plan should cover what’s best for patients, not what’s new

  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

A national pharmacare plan should cover what’s best for patients, not what’s new

  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
  • Using insulin is always challenging, so access to a broad range of appropriate options is vital.
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya

Can biotechnology put patients’ needs ahead of profits?

  • These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that 'waxed lyrical' about
Opinion | BY SHARON BATT | September 11, 2023
Prime Minister Justin Trudeau, pictured outside Rideau Hall on July 26, 2023, after shuffling his cabinet. 'Let’s hope the cabinet shuffle breathes ethical reflection into the government’s pursuit of excellence in the biotechnology sphere,' writes Sharon Batt. The Hill Times photograph by Andrew Meade

Can biotechnology put patients’ needs ahead of profits?

Opinion | BY SHARON BATT | September 11, 2023
  • These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that 'waxed lyrical' about

Can biotechnology put patients’ needs ahead of profits?

Opinion | BY SHARON BATT | September 11, 2023
  • These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that 'waxed lyrical' about
Prime Minister Justin Trudeau, pictured outside Rideau Hall on July 26, 2023, after shuffling his cabinet. 'Let’s hope the cabinet shuffle breathes ethical reflection into the government’s pursuit of excellence in the biotechnology sphere,' writes Sharon Batt. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu